Company / Inventory
Akebia Therapeutics, Inc. Inventory History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$15.6M
FY2025
5-year range
$15.6M / $38.2M
FY2021-FY2025
Trend
-3.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory has fluctuated over the past 8 years, ranging from $16M in FY2025 to $116M in FY2019.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of -23.9%.
Remained stable around $16M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -10.2%
- 5-Year CAGR
- -23.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -23.9%, indicating a declining trend.
- In FY2025, inventory decreased 3.9% year-over-year.
- Peak inventory was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.6M | -3.9% |
| FY2024 | $16.2M | +3.5% |
| FY2023 | $15.7M | -27.2% |
| FY2022 | $21.6M | -43.5% |
| FY2021 | $38.2M | -37.4% |
| FY2020 | $61.0M | -47.6% |
| FY2019 | $116.3M | +1.8% |
| FY2018 | $114.2M | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026